MedPath

Reward and Punishment Sensitivity in Bipolar Disorders

Conditions
Bipolar Disorder
Interventions
Behavioral: behavioral assessment
Registration Number
NCT04237610
Lead Sponsor
University Hospital, Grenoble
Brief Summary

Bipolar disorder (BD) represents a chronic mood disorder and one of the leading causes of disability worldwide. Complexity of its clinical presentations leads to delayed diagnosis and difficult management in routine clinical settings. Whereas distinguishing BD-I and BD-II main subtypes has a significant relevance for treatment strategy and for outcome, there are currently no clinical determinants of the BD subtype which could be used as early diagnostic predictors.

* While neurobiological specificity of each BD subtype is still controversial, available evidence suggest different dopaminergic abnormalities in each subtype. Dopaminergic function is involved in decision making and reward processing which may represent useful BD subtype markers.

* This study aims at assessing decision making during appetitive and punitive reinforcement learning in patients with BD I and BD II subtypes compared to healthy controls

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
90
Inclusion Criteria
  • bipolar disorder (BD) type I or II, according to DSM (Diagnostic and Statistical Manual)-5 criteria
  • Montgomery and Asberg Depression Rating Scale (MADRS) score < 15
  • Young Mania Rating Scale (YMRS) score < 12
Exclusion Criteria
  • other main diagnosis than bipolar disorder
  • other medical condition leading to cognitive deterioration

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
healthy controlsbehavioral assessment-
Bipolar disorder type Ibehavioral assessment-
Bipolar disorder type IIbehavioral assessment-
Primary Outcome Measures
NameTimeMethod
Response performance in reward and loss trialsone day visit

percentage of correct responses in the probabilistic learning task

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Grenoble Alpes

🇫🇷

Grenoble Cedex 9, France

© Copyright 2025. All Rights Reserved by MedPath